JP2023551602A5 - - Google Patents
Info
- Publication number
- JP2023551602A5 JP2023551602A5 JP2023553156A JP2023553156A JP2023551602A5 JP 2023551602 A5 JP2023551602 A5 JP 2023551602A5 JP 2023553156 A JP2023553156 A JP 2023553156A JP 2023553156 A JP2023553156 A JP 2023553156A JP 2023551602 A5 JP2023551602 A5 JP 2023551602A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063113657P | 2020-11-13 | 2020-11-13 | |
| US63/113,657 | 2020-11-13 | ||
| US202163136153P | 2021-01-11 | 2021-01-11 | |
| US63/136,153 | 2021-01-11 | ||
| US202163147165P | 2021-02-08 | 2021-02-08 | |
| US63/147,165 | 2021-02-08 | ||
| US202163181074P | 2021-04-28 | 2021-04-28 | |
| US63/181,074 | 2021-04-28 | ||
| US202163226032P | 2021-07-27 | 2021-07-27 | |
| US63/226,032 | 2021-07-27 | ||
| PCT/US2021/058979 WO2022103961A1 (en) | 2020-11-13 | 2021-11-11 | Methods, systems, and kits for treatment of inflammatory diseases targeting tl1a |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023551602A JP2023551602A (ja) | 2023-12-08 |
| JPWO2022103961A5 JPWO2022103961A5 (https=) | 2024-11-19 |
| JP2023551602A5 true JP2023551602A5 (https=) | 2024-11-19 |
Family
ID=81602611
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023553156A Pending JP2023551602A (ja) | 2020-11-13 | 2021-11-11 | Ｔｌ１ａを標的とする炎症性疾患の治療のための方法、システム、およびキット |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20230272098A1 (https=) |
| EP (1) | EP4244251A4 (https=) |
| JP (1) | JP2023551602A (https=) |
| KR (1) | KR20230140553A (https=) |
| AU (1) | AU2021377688A1 (https=) |
| BR (1) | BR112023009172A2 (https=) |
| CA (1) | CA3197828A1 (https=) |
| CL (1) | CL2024001693A1 (https=) |
| CO (1) | CO2023007607A2 (https=) |
| IL (1) | IL302791A (https=) |
| MX (1) | MX2023005688A (https=) |
| PH (1) | PH12023500011A1 (https=) |
| TW (1) | TW202233685A (https=) |
| WO (1) | WO2022103961A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102343212B1 (ko) | 2013-03-27 | 2021-12-23 | 세다르스-신나이 메디칼 센터 | Tl1a 기능 및 관련된 신호전달 경로의 저해에 의한 섬유증 및 염증의 완화 및 반전 |
| TWI703158B (zh) | 2015-09-18 | 2020-09-01 | 美商希佛隆公司 | 特異性結合tl1a之抗體 |
| TWI845600B (zh) | 2019-01-24 | 2024-06-21 | 美商普羅米修斯生物科學股份有限公司 | Gpr35調節劑 |
| JP2022533956A (ja) | 2019-05-14 | 2022-07-27 | プロメテウス バイオサイエンシーズ，インク． | Ｔｌ１ａ患者を選択する方法、システム、およびデバイス |
| WO2022232253A1 (en) * | 2021-04-28 | 2022-11-03 | Cedars-Sinai Medical Center | Patient selection methods and kits for therapies targeting tl1a |
| US20260066079A1 (en) * | 2022-11-23 | 2026-03-05 | Prometheus Biosciences, Inc. | Methods, systems, and kits for treatment of inflammatory diseases targeting tl1a |
| EP4646434A2 (en) * | 2023-01-06 | 2025-11-12 | Prometheus Biosciences, Inc. | Methods of treating inflammatory diseases with combination of tl1a inhibitors and tnf inhibitors |
| EP4646443A1 (en) * | 2023-01-06 | 2025-11-12 | Prometheus Biosciences, Inc. | Methods of treating inflammatory diseases with combination of tl1a inhibitors and integrin inhibitors |
| KR20260013470A (ko) * | 2023-05-17 | 2026-01-28 | 제넨테크, 인크. | 항-tl1a 항체 치료 방법 |
| CN121843714A (zh) | 2023-08-11 | 2026-04-10 | 派拉冈医疗公司 | Tl1a结合抗体及使用方法 |
| US12473370B2 (en) | 2023-10-03 | 2025-11-18 | Absci Corporation | TL1A associated antibody compositions and methods of use |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0004928D0 (sv) * | 2000-12-29 | 2000-12-29 | Apbiotech Ab | A method for the manufacturing of porous material |
| WO2002059264A2 (en) * | 2000-12-29 | 2002-08-01 | Bio-Technology General Corp. | Specific human antibodies for selective cancer therapy |
| WO2014186750A2 (en) * | 2013-05-17 | 2014-11-20 | Cedars-Sinai Medical Center | Variants of tnfsf15 and dcr3 associated with crohn's disease |
| MX388027B (es) * | 2013-11-13 | 2025-03-19 | Pfizer | Anticuerpos específicos para el ligando 1a tipo factor de necrosis tumoral y composiciones y usos de los mismos. |
| CR20180365A (es) * | 2015-12-16 | 2018-09-28 | Amgen Inc | PROTEÍNAS DE UNIÓN AL ANTÍGENO BISPECÍFICO DE ANTI-TL1A/ANTI-TNF-a Y SUS USOS |
| KR102481305B1 (ko) * | 2016-05-20 | 2022-12-26 | 세다르스-신나이 메디칼 센터 | 유전자에 기반한 염증성 장 질환의 진단 |
| US10626180B2 (en) * | 2017-04-20 | 2020-04-21 | Cedars-Sinai Medical Center | Methods of treating and predicting non-response to anti-TNF treatment in subjects with inflammatory bowel disease |
| JP7332627B2 (ja) * | 2018-04-25 | 2023-08-23 | プロメテウス バイオサイエンシーズ，インク． | 最適化された抗ｔｌ１ａ抗体 |
| ES2962715T3 (es) * | 2018-04-30 | 2024-03-20 | Cedars Sinai Medical Center | Métodos y sistemas para selección y tratamiento de pacientes con enfermedades inflamatorias |
| JP2022533956A (ja) * | 2019-05-14 | 2022-07-27 | プロメテウス バイオサイエンシーズ，インク． | Ｔｌ１ａ患者を選択する方法、システム、およびデバイス |
-
2021
- 2021-11-11 CA CA3197828A patent/CA3197828A1/en active Pending
- 2021-11-11 PH PH1/2023/500011A patent/PH12023500011A1/en unknown
- 2021-11-11 JP JP2023553156A patent/JP2023551602A/ja active Pending
- 2021-11-11 WO PCT/US2021/058979 patent/WO2022103961A1/en not_active Ceased
- 2021-11-11 KR KR1020237019762A patent/KR20230140553A/ko active Pending
- 2021-11-11 BR BR112023009172A patent/BR112023009172A2/pt unknown
- 2021-11-11 EP EP21892810.9A patent/EP4244251A4/en active Pending
- 2021-11-11 AU AU2021377688A patent/AU2021377688A1/en active Pending
- 2021-11-11 IL IL302791A patent/IL302791A/en unknown
- 2021-11-11 MX MX2023005688A patent/MX2023005688A/es unknown
- 2021-11-12 TW TW110142315A patent/TW202233685A/zh unknown
-
2023
- 2023-05-12 US US18/316,811 patent/US20230272098A1/en active Pending
- 2023-06-08 CO CONC2023/0007607A patent/CO2023007607A2/es unknown
-
2024
- 2024-06-07 CL CL2024001693A patent/CL2024001693A1/es unknown